Skip to search boxSkip to navigationSkip to main content

High-resolution structure of the HNF-1α dimerization domain

  • R. B. Rosea(Author)
    ,
  • J. A. Endrizzia(Author)
    ,
  • J. D. Cronkb(Author)
    ,
  • J. Holton(Author)
    ,
  • T. Alber(Author)
  • aUniversity of California, Berkeley
    ,
  • bFred Hutchinson Cancer Res. Center
Research Output: Contribution to journal Article Peer-review

Abstract

The N-terminal dimerization domain of the transcriptional activator hepatocyte nuclear factor-1α (HNF-1α) is essential for DNA binding and association of the transcriptional coactivator, DCoH (dimerization cofactor of HNF-1). To investigate the basis for dimerization of HNF-1 proteins, we determined the 1.2 Å resolution X-ray crystal structure of the dimerization domain of HNF-1α (HNF-p1). Phasing was facilitated by devising a simple synthesis for Fmoc-selenomethionine and substituting leucine residues with selenomethionine. The HNF-1 dimerization domain forms a unique, four-helix bundle that is preserved with localized conformational shifts in the DCoH complex. In three different crystal forms, HNF-p1 displays subtle shifts in the conformation of the interhelix loop and the crossing angle between the amino- and carboxyl-terminal helices. In all three crystal forms, the HNF-p1 dimers pair through an exposed hydrophobic surface that also forms the binding site for DCoH. Conserved core residues in the dimerization domain of the homologous transcriptional regulator HNF-1β rationalize the functional heterodimerization of the HNF-1α and HNF- 1β proteins. Mutations in HNF- 1α are associated with maturity-onset diabetes of the young type 3 (MODY3), and the structure of HNF-p1 provides insights into the effects of three MODY3 mutations.

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well